These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 39026679)

  • 1. Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma.
    Wu X; Hao L; Lin J; Guo X; Luo Y; Li C
    Front Immunol; 2024; 15():1399222. PubMed ID: 39026679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic biomarker of disulfidptosis constructed by machine learning framework model as potential reporters of pancreatic adenocarcinoma.
    Zhang W; Zhao Q; Zhang H; Zhang J; Zhao F; Niu R; Hu X; Wang L; Liu P
    Cell Signal; 2024 Nov; 123():111371. PubMed ID: 39209222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway.
    Yin YF; Jia QY; Yao HF; Zhu YH; Zheng JH; Duan ZH; Hu CY; Sun YW; Liu DJ; Huo YM; Liu W
    Gene; 2024 Nov; 927():148735. PubMed ID: 38944166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma.
    Zhou S; Guo Q; Chen A; Li X; Zou X
    World J Surg Oncol; 2024 Sep; 22(1):256. PubMed ID: 39342295
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
    Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    Li T; Zhao H; Zhou H; Geng T
    PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
    Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
    BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
    Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
    World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of epithelial splicing regulatory protein 1 (ESRP1) associated with tumor immunity in pancreatic adenocarcinoma.
    Wang P; Gao X; Zheng W; Zhang J
    J Proteomics; 2024 Sep; 308():105277. PubMed ID: 39127164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value and immunological role of MVP in pan-cancer study.
    Li C; Gao M; Zha N; Guo G
    Aging (Albany NY); 2024 May; 16(10):8497-8510. PubMed ID: 38713157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive exploration of immune checkpoint-related genes in the prognosis and tumor immune microenvironment of pancreatic adenocarcinoma.
    Chen X; Zhang H
    Clinics (Sao Paulo); 2024; 79():100481. PubMed ID: 39208654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation.
    Qiao S; Wu F; Wang H
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2108. PubMed ID: 38837874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas.
    Ge J; Ge J; Tang G; Xiong D; Zhu D; Ding X; Zhou X; Sang M
    J Transl Med; 2024 Aug; 22(1):775. PubMed ID: 39152432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of
    Jiang H; Xue Z; Zhao L; Wang B; Wang C; Song H; Sun J
    Biomol Biomed; 2024 Sep; 24(5):1231-1243. PubMed ID: 38520747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2.
    Lan S; Liu S; Wang K; Chen W; Zheng D; Zhuang Y; Zhang S
    Gene; 2024 Nov; 927():148739. PubMed ID: 38955307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis.
    Ma J; Chen Z; Hou L
    Aging (Albany NY); 2024 Sep; 16(18):12525-12542. PubMed ID: 39332020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.